MDS Virtual Congress 2021 Archives - Page 103 of 132

Nanopore single-molecule sequencing to investigate mitochondrial DNA CpG methylation in Parkinson’s disease

T. Lüth, K. Wasner, C. Klein, S. Schaake, R. Tse, S. Pereira, J. Laß, L. Sinkkonen, A. Grünewald, J. Trinh (Lübeck, Germany)
Natural History of Probable MSA in India: A Prospective Cohort Study

MR. Rukmani, R. Yadav, B. Bhaskarapillai, PK. Pal, TN. Sathyaprabha (Bangalore, India)
Neural correlates of executed compared to imagined writing and drawing movements. An fMRI study

C. Gless, A. Baumann, I. Tödt, A. Knutzen, O. Granert, S. Wolff, JS. Becktepe, K. Witt, KE. Zeuner (Kiel, Germany)
Neural oscillations modulation during working memory in premanifest and early Huntington’s disease

G. Bonassi, M. Semprini, P. Mandich, L. Trevisan, R. Marchese, G. Lagravinese, F. Barban, E. Pelosin, M. Chiappalone, D. Mantini, L. Avanzino (Genova, Italy)
Neural Signals in the Cerebellar Nuclei Gate the Manifestation of Dystonia-Associated Symptoms in Mice

M. Vander Heijden, T. Lin, D. Kizek, A. Brown, R. Sillitoe (Houston, USA)
Neuro-Behavioral Therapy for Functional Movement Disorders: Conceptual Framework and Future Directions

J. Mack, WC. Lafrance, JR. (Portland, USA)
Neuroanatomical signatures of genetic risk for Parkinson’s Disease in healthy adults

S. Waters, J. Kim, C. Watson, B. Jacobs, I. Foote, S. Dey, C. Blauwendraat, A. Noyce, C. Marshall (London, United Kingdom)
Neurofilament light chain serum levels in E46K-SNCA mutation carriers

A. Murueta-Goyena, MA. Acera, N. Ayo, M. Carmona-Abellán, R. Del Pino, I. Gabilondo, B. Tijero, T. Fernandez, M. Ruiz, JC. Gómez-Esteban, E. Capetillo, R. Cipriani, F. Zallo, F. Cavaliere (Barakaldo, Spain)
Neurofilament light is related to fractional anisotropy in early Parkinson’s diesease

T. Welton, Y. Tan, S. Saffari, N. Chia, S. Ng, Z. Lu, A. Yong, X. Choi, D. Heng, YC. Shih, S. Hartono, W. Lee, Z. Xu, K. Tay, WL. Au, EK. Tan, LL. Chan, A. Ng, L. Tan (Singapore, Singapore)
Neurogenetic Traits Outline Vulnerability to Cortical Disruption in Parkinson’s Disease

S. Basaia, F. Agosta, I. Diez Palacio, E. Bueichekú, F. D’Oleire Uquillas, M. Delgado-Alvarado, C. Caballero-Gaudes, M. Rodriguez-Oroz, T. Stojkovic, V. Kostic, M. Filippi, J. Sepulcre (Milan, Italy)
Neuroimaging associations to gait impairments in progressive supranuclear palsy

I. Sintini, K. Kaufman, S. Loushin, H. Botha, P. Martin, M. Senjem, R. Reid, C. Schwarz, C. Jack, V. Lowe, K. Josephs, J. Whitwell, F. Ali (Rochester, USA)
Neuroinflammation and Anti-Psychotic Drugs Induced Hyperkinesia or Dystonia in Treatment of Organic Brain Psychoses and Schizophrenia

D. Labunskiy, S. Kiryukhina, V. Kolmykov, E. Govsh, D. Baranov, E. Razgadova (Saransk, Russian Federation)
Neuroleptic Malignant Syndrome: Case Series of Movement Disorders Emergency

IAH. Hakim, NR. Raisa, WMS. Santoso, CAS. Setianto (Malang, Indonesia)
Neuronal intranuclear inclusion disease tremor-dominant subtype: a mimicker of essential tremor

D. Yang, Z. Cen, L. Wang, X. Chen, P. Liu, H. Wang, Z. Ouyang, W. Luo (Hangzhou, China)
Neurophysiological features of the premotor cortex excitability parameters after a course of therapeutic transcranial magnetic stimulation in patients with Parkinson’s disease stage II living in the Zaporizhzhya region

A. Demchenko, A. Revenko, DJ. Aravitskaya (Zaporizhzhya, Ukraine)
Neuroprotective Epigenetic and DNA-Repair Molecular Mechanisms of Acetyl-L-Carnitine and Astaxanthin Against 6-OHDA Induced Parkinsonism in Aged Rats

S. Kumar, P. Kumar, A. Williams, M. Anifowose, K. Ponnusamy (Puducherry, India)
Neuropsychiatric evaluation in patients with functionel movements disorders

M. Balal, S. çakmak, M. Demirkiran (Adana, Turkey)
Neuropsychiatric Issues in Parkinson’s Disease

F. Aziouaz, Y. Mebrouk (Oujda, Morocco)
Neutralizing Antibody Conversion With OnabotulinumtoxinA From Global Studies Across Multiple Indications With A Focus On Movement Disorders: A Meta-Analysis

J. Jankovic, J. Carruthers, M. Naumann, T. Boodhoo, S. Gupta, M. Attar, R. Singh, I. Yushmanova, J. Soliman, MF. Brin, J. Shen (Houston, USA)
New insight into REM-sleep atonia circuits underlying REM sleep behavior disorder in living humans

M. Garcia Gomar, A. Videnovic, K. Singh, M. Stauder, L. Lewis, L. Wald, B. Rossen, M. Bianciardi (Charlestown, USA)
New presenilin-1 missense variant (p.Pro88Arg) characterized by initial progressive supranuclear palsy like phenotype.

Q. Thomas, S. Nambot, C. Thauvin-Robinet, C. Philippe, Y. Bejot, G. Dupont (Dijon, France)
New-onset movement disorders in patients with COVID-19 from two centers in Western India

S. Adukia, S. Panat, M. Munshi, P. Joshi, K. Shetty, T. Singhal, M. Bhatt, A. Aggarwal (Mumbai, India)
Next-generation sequencing of plasma-associated extracellular vesicle miRNAs as potential biomarkers for Parkinson’s disease and its prodromal stage

L. Li, L. Liu (Shanghai, China)
Night Vision Blindness Should Be Discussed with our Parkinson’s Disease Patients – sooner rather than later.

L. Jaffe (Honolulu, USA)
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson’s Disease

L. Gibson, T. Pollak, M. Hart, D. Trivedi, T. Nicholson, M. Zandi, K R. Chaudhuri, D. Aarsland (London, United Kingdom)
Non-invasive imaging markers of iron accumulation in Multiple System Atrophy

D. Claassen, P. Trujillo, D. Buchanan, K. Hett, C. Wong, D. Stamler (Nashville, USA)
Non-Motor Symptoms in Cervical Dystonia Patients

L. Shperling (Novosibirsk, Russian Federation)
Non-motor symptoms in Parkinson’s disease

M. Elfekih, I. Bedoui, B. Douma, M. Mansour, H. Derbali, A. Riahi, M. Meselmani, J. Zaouali, R. Mrissa (Nabeul, Tunisia)
Non-Motor Symptoms Progression After 2 years Follow-up in Parkinson´s Disease. Results from the COPPADIS Cohort and Comparison with a Control Group

C. Cores Bartolomé, D. García, T. Fonticoba, C. Miró, E. Castro, JM. Gonzalez, S. Maestre, M. Aguilar, P. Pastor, L. Planellas Giné, M. Cosgaya, J. Garcia Caldentey, N. Caballol Pons, I. Legarda Ramirez, J. Hernandez Vara, I. Cabo, L. Lopez Manzanares, I. Gonzalez Aramburu, MA. Avila, MJ. Catalan Alonso, V. Nogueira, V. Puente, JM. Garcia Moreno, C. Borrue Fernandez, B. Solano Vila, M. Alvarez Sauco, L. Vela Desojo, S. Escalante, E. Cubo, F. Carrillo Padilla, JC. Martinez Castrillo, P. Sanchez Alonso, MG. Alonso Losada, N. Lopez Ariztegui, I. Gaston Zubimendi, J. Kulisevsky, M. Blazquez Estrada, M. Seijo Martinez, J. Ruiz Martinez, C. Valero Merino, M. Kurtis, O. de Fábregues-Boixer, J. Gonzalez Ardura, CM. Ordas Bandera, L. Lopez Diaz, P. Mir Rivera, P. Martinez Martin (A Coruña, Spain)
NON-STRUCTURAL HEMICHOREA: REPORT OF NINE CASES

B. Charra, V. Kurtz, J. Prez, G. Lopez, E. Garino, D. Ballesteros (Buenos Aires, Argentina)
Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias

I. Walker, S. Shaw, S. Vaishnavi, D. Wolk, N. Dahodwala, J. Morley, J. Duda, A. Chen-Plotkin, A. Siderowf, L. Shaw, E. Lee, J. Trojanowski, M. Grossman, D. Weintraub, D. Irwin (Philadelphia, USA)
Nonmotor effects of subthalamic stimulation in Parkinson’s disease motor subtypes

S. Jost, A. Konitsioti, P. Loehrer, K. Ashkan, A. Rizos, A. Sauerbier, M. Ghilardi, F. Rosenkranz, L. Strobel, A. Gronostay, M. Barbe, J. Evans, M. Silverdale, R. Cury, E. Fonoff, G. Fink, A. Antonini, C. Nimsky, K. Ray Chaudhuri, L. Timmermann, V. Visser-Vandewalle, P. Martinez-Martin, H. Dafsari (Cologne, Germany)
Nonmotor Symptoms in Huntington disease in relation to the Diagnostic Confidence Level

N. Rocha, M. Edmondson, C. Testa, J. Patino, M. Rossetti, A. Teixeira, E. Furr Stimming (Houston, USA)
Normal chorein protein signal on Western blot despite VPS13A mutations in VPS13A disease

G. Miltenberger-Miltenyi, B. Bader, A. Velayos-Baeza, L. Burghaus, P. Goldsmith, A. Abicht, R. Bhidayasiri, N. Balakrishnan, D. Simon, R. Walker, N. Lubarr, A. Danek (Munich, Germany)
Normal-sized Perivascular Space in Basal Ganglia Related to Motor Phenotypes in Parkinson Freezers

Y. Yue, W. Lv, T. Shen, XY. Hu, H. Lai, F. Ba (Hangzhou, China)
Normative data for six standardized motor tasks in healthy adults

H. Röhling, K. Otte, R. Rust, B. Behnia, F. Paul, T. Schmitz-Hübsch (Berlin, Germany)
Novel approach to MDS-UPDRS monitoring in clinical trials: Longitudinal Item Response Theory Models

S. Luo, H. Zou, C. Goetz, D. Choi, D. Oakes, T. Simuni, G. Stebbins (Durham, USA)
Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy

M. Brzezicki, C. Antoniades (Oxford, United Kingdom)
Novel PLA2G6 Mutation Presenting as Early-Onset Parkinson’s Disease

J. Hislop, E. Saraf Lavi, D. Barbouth, M. Foley, H. Moore, C. Singer (Miami, USA)
Novel quantitative measures with standardised graphical tasks to objectively assess subtle changes in fine motor skill in diagnosing and monitoring of Parkinson’s disease

R. Zietsma, A. Karki, O. Taylor, A. Deutschlander, R. Walker (Edinburgh, United Kingdom)
Nurse-led rapid access mental health clinic: a new care pathway in Parkinson’s disease

S. Lidstone, K. Marcelle (Toronto, Canada)